Information:
Fel:
ID
30409
Beskrivning
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362972
Länk
https://clinicaltrials.gov/show/NCT01362972
Nyckelord
Versioner (1)
- 2018-06-03 2018-06-03 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
3 juni 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lymphoma NCT01362972
Eligibility Lymphoma NCT01362972
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT01362972
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Inclusion Cohort Analysis | Criteria Fulfill
Item
for inclusion in the cohort analysis, patients must have data in the ebmt registry that meet the following criteria:
boolean
C1512693 (UMLS CUI [1,1])
C0086027 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
C0086027 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Adult | Lymphoma | Multiple Myeloma
Item
adults diagnosed with lymphoma or multiple myeloma (mm)
boolean
C0001675 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
Autologous peripheral blood stem cell transplant First | Manipulation Stem cells
Item
received first autologous transplants of peripheral blood (pb) non ex-vivo manipulated stem cells in the time period listed above using cells mobilised with one of the following regimens:
boolean
C1960579 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0947647 (UMLS CUI [2,1])
C0038250 (UMLS CUI [2,2])
C0205435 (UMLS CUI [1,2])
C0947647 (UMLS CUI [2,1])
C0038250 (UMLS CUI [2,2])
Plerixafor | G-CSF
Item
plerixafor plus granulocyte colony stimulating factor (g-csf)
boolean
C1955474 (UMLS CUI [1])
C0079459 (UMLS CUI [2])
C0079459 (UMLS CUI [2])
Plerixafor | G-CSF | Chemotherapy
Item
plerixafor plus g-csf plus chemotherapy
boolean
C1955474 (UMLS CUI [1])
C0079459 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C0079459 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
G-CSF Alone
Item
g-csf alone or
boolean
C0079459 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,2])
G-CSF | Chemotherapy
Item
g-csf plus chemotherapy
boolean
C0079459 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Plerixafor Group | Therapeutic procedure in accordance with Label
Item
note: patients included in the plerixafor groups will be those treated according to the label
boolean
C1955474 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C4281991 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0441833 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C4281991 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
Informed Consent
Item
provision of informed consent (i.e., all patients with data in the ebmt registry will have signed consent at the time of transplantation for the potential use of their data for analysis)
boolean
C0021430 (UMLS CUI [1])
Plerixafor | Agreement European Union Label Lacking
Item
patients treated with plerixafor not according to the european union (eu) label.
boolean
C1955474 (UMLS CUI [1])
C0680240 (UMLS CUI [2,1])
C0015179 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0332268 (UMLS CUI [2,4])
C0680240 (UMLS CUI [2,1])
C0015179 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0332268 (UMLS CUI [2,4])
Graft material ex vivo Manipulation
Item
patients whose graft product underwent ex vivo manipulation will be excluded from analysis
boolean
C0181074 (UMLS CUI [1,1])
C2348480 (UMLS CUI [1,2])
C0947647 (UMLS CUI [1,3])
C2348480 (UMLS CUI [1,2])
C0947647 (UMLS CUI [1,3])